A woman who sued Wyeth, claiming her breast cancer was caused by the company’s hormone replacement drug, did not show sufficient evidence that her doctor wouldn’t have prescribed the drug if warnings were better, a Philadelphia judge explained as to why he overturned a $3 million jury award.
Philadelphia Common Pleas Senior Judge Ricardo C. Jackson outlined for the Superior Court Thursday why his grant of JNOV and his denial of a punitive damages phase in Nelson v. Wyeth should be upheld.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
